Copyright © 2000 by the European Society of Cardiology.
Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men
Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna, Central Laboratory, S. Orsola-Malpighi Hospital, Bologna, Italy
Received September 30, 1999; accepted November 17, 1999
Abstract
Aims Serum C3 is a powerful indicator of the risk of myocardial infarction, which correlates with body mass index, serum lipids and blood pressure. This study was performed to ascertain whether such correlations may be explained by an association of C3 with fasting insulin, and to assess comparatively the relationships of C3 and traditional risk factors to previous myocardial infarction.
Methods and Results The fasting levels of C3, insulin, and the main risk factors were evaluated in 1090 unselected men aged 55-64 years, including 129 cases of previous ischaemic events (51 myocardial infarctions). In multivariate analysis C3 was associated with insulin (r=0·27,P <0·0001), cholesterol (r=0·18, P<0·0001), body mass index (r=0·13, P<0·0001), glucose (r=0·12, P=0·0001), systolic blood pressure (r=0·10, P<0·001), triglycerides (r=0·09, P<0·01) and HDL-cholesterol (r=–0·06, P<0·05). These variables explained 31% of the total C3 variance. Alcohol consumption and physical activity correlated inversely with C3, while no correlation was found with smoking and family history of myocardial infarction. C3 was associated with previous myocardial infarction and stroke, but not with angina pectoris and peripheral arterial disease. In logistic regression the variables associated with previous myocardial infarction were C3 (P=0·011), family history of myocardial infarction (P=0·018), ex-smoker status (P=0·020), age (P=0·025), glucose (P=0·028) and HDL-cholesterol (P=0·051, inverse relationship).
Conclusions The association of C3 with myocardial infarction persists retrospectively, and is more significant than any other association of traditional risk factors with previous myocardial infarction. Of the many variables associated with C3, fasting insulin is its main covariate, which suggests that C3 is a marker of a pro-atherogenic metabolic imbalance partly coinciding with insulin resistance.
Key Words: Complement-3, insulin, risk factors, myocardial infarction
f1 Correspondence: Antonio Muscari, MD, Department of Internal Medicine, Cardioangiology, Hepatology, University of Bologna–S. Orsola-Malpighi Hospital, Via Massarenti, 9-40138 Bologna, Italy.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. R. La Bonte, G. Davis-Gorman, G. L. Stahl, and P. F. McDonagh Complement inhibition reduces injury in the type 2 diabetic heart following ischemia and reperfusion Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1282 - H1290. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Muscari, S. Antonelli, G. Bianchi, G. Cavrini, S. Dapporto, A. Ligabue, C. Ludovico, D. Magalotti, G. Poggiopollini, M. Zoli, et al. Serum C3 Is a Stronger Inflammatory Marker of Insulin Resistance Than C-Reactive Protein, Leukocyte Count, and Erythrocyte Sedimentation Rate: Comparison study in an elderly population Diabetes Care, September 1, 2007; 30(9): 2362 - 2368. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Somani, P. J. Grant, K. Kain, A. J. Catto, and A. M. Carter Complement C3 and C-Reactive Protein Are Elevated in South Asians Independent of a Family History of Stroke Stroke, August 1, 2006; 37(8): 2001 - 2006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. Speidl, M. Exner, J. Amighi, S. P. Kastl, G. Zorn, G. Maurer, O. Wagner, K. Huber, E. Minar, J. Wojta, et al. Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis Eur. Heart J., November 1, 2005; 26(21): 2294 - 2299. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. H. van Wijk, M. C. Cabezas, E. J. P. de Koning, T. J. Rabelink, R. van der Geest, and I. M. Hoepelman In Vivo Evidence of Impaired Peripheral Fatty Acid Trapping in Patients with Human Immunodeficiency Virus-Associated Lipodystrophy J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3575 - 3582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Anderson Candidate-based proteomics in the search for biomarkers of cardiovascular disease J. Physiol., February 15, 2005; 563(1): 23 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Engstrom, B. Hedblad, K.-F. Eriksson, L. Janzon, and F. Lindgarde Complement C3 Is a Risk Factor for the Development of Diabetes: A Population-Based Cohort Study Diabetes, February 1, 2005; 54(2): 570 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J van Oostrom, H. van Dijk, C. Verseyden, A. D Sniderman, K. Cianflone, T. J Rabelink, and M. Castro Cabezas Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3 Am. J. Clinical Nutrition, March 1, 2004; 79(3): 510 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yilmazer, V. Fenkci, S. Fenkci, O. Aktepe, M. Sonmezer, and G. Kurtay Association of serum complement (C3, C4) and immunoglobulin (IgG, IgM) levels with hormone replacement therapy in healthy post-menopausal women Hum. Reprod., July 1, 2003; 18(7): 1531 - 1535. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Fernandez-Real and W. Ricart Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome Endocr. Rev., June 1, 2003; 24(3): 278 - 301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. H. H. M. van Oostrom, T. P. Sijmonsma, C. Verseyden, E. H. J. M. Jansen, E. J. P. de Koning, T. J. Rabelink, and M. Castro Cabezas Postprandial recruitment of neutrophils may contribute to endothelial dysfunction J. Lipid Res., March 1, 2003; 44(3): 576 - 583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.J.M. Halkes, H. van Dijk, P.P.T. de Jaegere, H.W.M. Plokker, Y. van der Helm, D. W. Erkelens, and M. Castro Cabezas Postprandial Increase of Complement Component 3 in Normolipidemic Patients With Coronary Artery Disease: Effects of Expanded-Dose Simvastatin Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1526 - 1530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.S. Yudkin Relationship of serum C3 complement with insulin resistance and coronary heart disease--cause, consequence or common antecedent? Eur. Heart J., July 1, 2000; 21(13): 1036 - 1039. [PDF]
|
|